AAAAAA
Results:
1-17
|
Results: 17
Authors:
KEUNG ACF
ELLER MG
WEIR SJ
Citation: Acf. Keung et al., SINGLE-DOSE PHARMACOKINETICS OF RIFAPENTINE IN ELDERLY MEN, Pharmaceutical research, 15(8), 1998, pp. 1286-1291
Authors:
ROBBINS DK
CASTLES MA
PACK DJ
BHARGAVA VO
WEIR SJ
Citation: Dk. Robbins et al., DOSE PROPORTIONALITY AND COMPARISON OF SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF FEXOFENADINE (MDL 16455) AND ITS ENANTIOMERS IN HEALTHYMALE-VOLUNTEERS, Biopharmaceutics & drug disposition, 19(7), 1998, pp. 455-463
Authors:
WEIR SJ
DIMMITT DC
LANMAN RC
MORRILL MB
GEISING DH
Citation: Sj. Weir et al., STEADY-STATE PHARMACOKINETICS OF DILTIAZEM AND HYDROCHLOROTHIAZIDE ADMINISTERED ALONE AND IN COMBINATION, Biopharmaceutics & drug disposition, 19(6), 1998, pp. 365-371
Authors:
DIMMITT DC
SHAH AK
ARUMUGHAM T
CRAMER IB
HALSTENSON C
HORTON M
WEIR SJ
Citation: Dc. Dimmitt et al., PHARMACOKINETICS OF ORAL AND INTRAVENOUS DOLASETRON MESYLATE IN PATIENTS WITH RENAL IMPAIRMENT, Journal of clinical pharmacology, 38(9), 1998, pp. 798-806
Authors:
KEUNG ACF
ELLER MG
WEIR SJ
Citation: Acf. Keung et al., PHARMACOKINETICS OF RIFAPENTINE IN PATIENTS WITH VARYING DEGREES OF HEPATIC-DYSFUNCTION, Journal of clinical pharmacology, 38(6), 1998, pp. 517-524
Authors:
REITH K
KEUNG A
TOREN PC
CHENG L
ELLER MG
WEIR SJ
Citation: K. Reith et al., DISPOSITION AND METABOLISM OF C-14-RIFAPENTINE IN HEALTHY-VOLUNTEERS, Drug metabolism and disposition, 26(8), 1998, pp. 732-738
Authors:
KEUNG ACF
ELLER MG
WEIR SJ
Citation: Acf. Keung et al., SINGLE-DOSE PHARMACOKINETICS OF RIFAPENTINE IN WOMEN, Journal of pharmacokinetics and biopharmaceutics, 26(1), 1998, pp. 75-85
Authors:
ROBBINS DK
HUTCHESON SJ
MILLER TD
GREEN VI
BHARGAVA VO
WEIR SJ
Citation: Dk. Robbins et al., PHARMACOKINETICS OF MDL-26479, A NOVEL BENZODIAZEPINE INVERSE AGONIST, IN NORMAL VOLUNTEERS, Biopharmaceutics & drug disposition, 18(4), 1997, pp. 325-334
Authors:
YU DK
BHARGAVA VO
WEIR SJ
Citation: Dk. Yu et al., SELECTION OF DOSES FOR PHASE-II CLINICAL-TRIALS BASED ON PHARMACOKINETIC VARIABILITY CONSIDERATION, Journal of clinical pharmacology, 37(8), 1997, pp. 673-678
Authors:
SHAH AK
WEI G
LANMAN RC
BHARGAVA VO
WEIR SJ
Citation: Ak. Shah et al., PERCUTANEOUS-ABSORPTION OF KETOPROFEN FROM DIFFERENT ANATOMICAL SITESIN MAN, Pharmaceutical research, 13(1), 1996, pp. 168-172
Authors:
RAO N
BHARGAVA VO
REYNOLDS DL
ELLER MG
WEIR SJ
Citation: N. Rao et al., AN INVESTIGATION OF THE DOSE PROPORTIONALITY OF DEFLAZACORT PHARMACOKINETICS, Biopharmaceutics & drug disposition, 17(9), 1996, pp. 753-760
Authors:
LIPPERT CL
ARUMUGHAM T
BHARGAVA VO
ELLER M
WEIR SJ
Citation: Cl. Lippert et al., THE RELATIVE BIOAVAILABILITY OF 2 MARKETED CONTROLLED-RELEASE DILTIAZEM DOSAGE FORMS AT STEADY-STATE IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 17(1), 1996, pp. 43-53
Authors:
YU DK
NORDBROCK E
HUTCHESON SJ
LEWIS EW
SULLIVAN W
BHARGAVA VO
WEIR SJ
Citation: Dk. Yu et al., POPULATION PHARMACOKINETICS OF TEICOPLANIN IN PATIENTS WITH ENDOCARDITIS, Journal of pharmacokinetics and biopharmaceutics, 23(1), 1995, pp. 25-39
Authors:
YU DK
MORRILL B
EICHMEIER LS
LANMAN RC
LANMAN MB
GIESING DH
WEIR SJ
Citation: Dk. Yu et al., PHARMACOKINETICS OF 5-AMINOSALICYLIC ACID FROM CONTROLLED-RELEASE CAPSULES IN MAN, European Journal of Clinical Pharmacology, 48(3-4), 1995, pp. 273-277
Authors:
YU DK
HUTCHESON SJ
WEI G
BHARGAVA VO
WEIR SJ
Citation: Dk. Yu et al., A COMPARISON OF POPULATION AND STANDARD 2-STAGE PHARMACOKINETIC ANALYSES OF VIGABATRIN DATA, Biopharmaceutics & drug disposition, 15(6), 1994, pp. 473-484
Authors:
WEIR SJ
Citation: Sj. Weir, THE EFFECTS OF FEMINIST APPROACHES ON RESEARCH METHODOLOGIES - TOMM,W, Women & politics, 13(1), 1993, pp. 95-96
Authors:
BHARGAVA VO
SHAH AK
WEIR SJ
NORDBROCK EE
GIESING DH
Citation: Vo. Bhargava et al., SINGLE AND MULTIPLE ORAL DOSE PHARMACOKINETICS OF CLENTIAZEM IN NORMAL VOLUNTEERS, Journal of clinical pharmacology, 33(5), 1993, pp. 439-443
Risultati:
1-17
|